| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/08/2004 | EP1484398A1 Human glioma antigen originating in testis |
| 12/08/2004 | EP1484395A1 Transposon being functional in mammals |
| 12/08/2004 | EP1484393A1 Polynucleotide for target gene |
| 12/08/2004 | EP1484392A1 Diacylglycerol acyltransferase genes, proteins and uses thereof |
| 12/08/2004 | EP1484391A1 Vaccine against mumps |
| 12/08/2004 | EP1484340A1 Antibodies to a novel mammalian protein associated with uncontrolled cell division |
| 12/08/2004 | EP1484339A2 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 12/08/2004 | EP1484338A1 Methods and compositions for inhibiting neoplastic cell growth |
| 12/08/2004 | EP1484066A1 Remedy for infections |
| 12/08/2004 | EP1484063A2 Method for inhibiting rejection of transplanted tissue |
| 12/08/2004 | EP1483962A2 Transgenic animal model for Glyt1 function |
| 12/08/2004 | EP1483720A1 Computer systems and methods for identifying genes and determining pathways associated with traits |
| 12/08/2004 | EP1483590A1 Positioning system for moving a selected station of a holding plate to a predetermined location for interaction with a probe |
| 12/08/2004 | EP1483588A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 12/08/2004 | EP1483587A2 Tagging and recovery of elements associated with target molecules |
| 12/08/2004 | EP1483583A2 Acyl fluoride activation of carboxysilyl-coated glass substrates |
| 12/08/2004 | EP1483576A2 Novel method for detecting and analyzing protein interactions in vivo |
| 12/08/2004 | EP1483573A1 Vertical impedance sensor arrangement and method for producing a vertical impedance sensor arrangement |
| 12/08/2004 | EP1483415A2 A non-invasive diagnostic test utilizing histone modification markers |
| 12/08/2004 | EP1483410A1 Method and device for determination of tissue specificity of free floating dna in bodily fluids |
| 12/08/2004 | EP1483409A1 Method of error reduction in nucleic acid populations |
| 12/08/2004 | EP1483408A1 Nanostructures containing pna joining or functional elements |
| 12/08/2004 | EP1483406A1 Headloop dna amplification |
| 12/08/2004 | EP1483404A2 Methods for detecting genome-wide sequence variations associated with a phenotype |
| 12/08/2004 | EP1483403A2 Enzymatic ligation-based identification of nucleotide sequences |
| 12/08/2004 | EP1483402A1 Apparatus and method for amplifying a polynucleotide |
| 12/08/2004 | EP1483401A1 Method for selecting drug sensitivity-determining factors and method for predicting drug sensitivity using the selected factors |
| 12/08/2004 | EP1483400A1 Use of the axl receptor for diagnosis and treatment of renal disease |
| 12/08/2004 | EP1483398A2 Method for producing riboflavin |
| 12/08/2004 | EP1483396A2 Wit 3.0, novel gene to control soft tissue wound healing |
| 12/08/2004 | EP1483393A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
| 12/08/2004 | EP1483392A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
| 12/08/2004 | EP1483391A1 Engineered baculoviruses and their use |
| 12/08/2004 | EP1483390A2 Transgenic plants synthesising high amylose starch |
| 12/08/2004 | EP1483389A2 Genetic products differentially expressed in tumors and use thereof |
| 12/08/2004 | EP1483388A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 12/08/2004 | EP1483387A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
| 12/08/2004 | EP1483385A2 Compositions and methods for generating an immune response |
| 12/08/2004 | EP1483384A2 Method for overexpression of zwitterionic polysaccharides |
| 12/08/2004 | EP1483382A1 Alleles of the acea gene from coryneform bacteria |
| 12/08/2004 | EP1483381A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 12/08/2004 | EP1483380A2 Recombinant protein c variants |
| 12/08/2004 | EP1483376A1 High throughput system for producing recombinant viruses using site-specific recombination |
| 12/08/2004 | EP1483375A1 A method for producing recombinant viruses using site-specific recombination |
| 12/08/2004 | EP1483369A1 Avian cell lines for the production of useful substances |
| 12/08/2004 | EP1483367A2 Bacteria with reduced genome |
| 12/08/2004 | EP1483298A2 Materials and methods for preparing dimeric growth factors |
| 12/08/2004 | EP1483297A2 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 12/08/2004 | EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 12/08/2004 | EP1483288A2 Hbm variants that modulate bone mass and lipid levels |
| 12/08/2004 | EP1483282A1 RIBOZYMES WITH BROAD tRNA AMINOACYLATION ACTIVITY |
| 12/08/2004 | EP1483281A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
| 12/08/2004 | EP1482989A1 Inactivation of microbes in biological fluids |
| 12/08/2004 | EP1482984A2 Surrogate antibodies and methods of preparation and use thereof |
| 12/08/2004 | EP1482982A1 Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereof |
| 12/08/2004 | EP1482975A2 Prevention of tissue adhesion |
| 12/08/2004 | EP1482974A2 Electroporation methods for introducing bioactive agents into cells |
| 12/08/2004 | EP1482973A1 Methods of modulating cd200 receptors |
| 12/08/2004 | EP1482962A2 Method of treating trx mediated diseases |
| 12/08/2004 | EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 12/08/2004 | EP1482807A2 Food fermentation with lactic acid bacteria |
| 12/08/2004 | EP1482803A2 Plant preparations |
| 12/08/2004 | EP1482793A2 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 12/08/2004 | EP1482779A2 Heat stable mutants of starch biosynthesis enzymes |
| 12/08/2004 | EP1444345A4 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 12/08/2004 | EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor |
| 12/08/2004 | EP1421175A4 Polymer stabilized proteinases |
| 12/08/2004 | EP1386150A4 Insect ammunition vectors and methods of use to identify pesticide targets |
| 12/08/2004 | EP1362101B1 Orientation-directed construction of plasmids |
| 12/08/2004 | EP1330553A4 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 12/08/2004 | EP1326960B1 Microbes having an attenuating mutation comprising a transcription terminator |
| 12/08/2004 | EP1290147A4 Directed evolution of oxidase enzymes |
| 12/08/2004 | EP1266033A4 Method of reverse transcription using bacillus steraothermophilus or thermoactinomyces vulgaris dna polymerase |
| 12/08/2004 | EP1240355A4 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 12/08/2004 | EP1143797A4 Methods for reducing adverse side effects associated with cellular transplantation |
| 12/08/2004 | EP1141014B1 Insulin-like growth factor (igf) i mutant variant |
| 12/08/2004 | EP1120461B1 Process for producing copolymerized polyester |
| 12/08/2004 | EP1056858B1 RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3) |
| 12/08/2004 | EP1015015A4 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY |
| 12/08/2004 | EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 12/08/2004 | EP0991765B1 Resistance marker for monocotyledons |
| 12/08/2004 | EP0984925B1 Compounds, preparation and use for transferring nucleic acids into cells |
| 12/08/2004 | EP0966535B1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides |
| 12/08/2004 | EP0833941A4 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 12/08/2004 | EP0824548B1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits |
| 12/08/2004 | EP0782628B1 Improvement of an expression vector for production of recombinant proteins |
| 12/08/2004 | EP0781291B1 Process for isolating cellular substances such as nucleic acids from natural sources |
| 12/08/2004 | EP0711353B1 Production of trehalose in plants |
| 12/08/2004 | CN1554026A Prognostic indicator |
| 12/08/2004 | CN1553963A Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 12/08/2004 | CN1553962A System for detecting protease |
| 12/08/2004 | CN1553961A Membrane virus host range mutations and their uses as vaccine substrates |
| 12/08/2004 | CN1553958A Photochemical internalization for delivery of molecules into the cytosol |
| 12/08/2004 | CN1553957A Mutant bacterial strains of the genus sphingonomas deficient in production of polyhydroxybutyrate and a process of clarification of sphingans and compositions thereof |
| 12/08/2004 | CN1553956A Novel genetic products of ashbya gossypii, associated with transmembrane transport |
| 12/08/2004 | CN1553955A Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof |
| 12/08/2004 | CN1553954A Method for increasing productivity of secondary metabolite by conferring drug-resistant mutations |
| 12/08/2004 | CN1553953A Real-time sequence determination |
| 12/08/2004 | CN1553950A Method for increasing stress tolerance in plants |
| 12/08/2004 | CN1553916A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |